Xconomy Boston

Pervasis Therapeutics Secures $9,750,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=78a8bb6d-7436-4b20-a614-b0c9b8446bd5&Preview=1
Date
1/15/2008
Company Name
Pervasis Therapeutics
Mailing Address
One Kendall Square, Building 600 Cambridge, MA 02139
Company Description
Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.
Website
http://www.pervasistx.com
Transaction Type
Venture Equity
Transaction Amount
$9,750,000
Transaction Round
Undisclosed
Proceeds Purposes
The new investment will support further development of Pervasis’ innovative Vascugel® blood vessel repair therapeutic, presently in two Phase II clinical trials, as well as continuing research into expanding the product’s projected uses into additional vascular and non-vascular applications, including cardiovascular and other indications.
M&A Terms
Venture Investor
Flagship Ventures
Venture Investor
Polaris Venture Partners
Venture Investor
Highland Capital Partners